News & Insights

Functional Medicine News & Emerging Research

News

Save the Date: 2019 Annual International Conference

Stress, pain, and addictions form an intersecting triad of problems plaguing all modern industrial societies. Each of these can be a cause and an effect, a trigger and a mediator. All three are fundamental underlying causes of morbidity and mortality, and can be linked together in various ways…

Read More
News

IFM Names Terry Wahls, MD, as the 2018 Linus Pauling Award Recipient

IFM is proud to announce Terry Wahls, MD, as the 2018 recipient of the Linus Pauling Award. Dr. Wahls received this award for her work as a physician, researcher, teacher, and patient advocate. Read More
News

The Functional Medicine Coaching Academy's Role in IFM's Mission

The Functional Medicine Coaching Academy (FMCA) has trained over 1,000 health coaches and developed several other exciting ways to help Functional Medicine practitioners integrate health coaching into their practices. Read More
News

IFM’s Nominations For Your Consideration: The First Evolution of Medicine Awards

At the end of May, IFM will convene the largest international gathering of the Functional Medicine practitioner community at our Annual International Conference. The Evolution of Medicine is hosting a gathering the evening before our Annual Conference to celebrate the “best of” in our community... Read More
Insights
Group 2

How Do Gut Bacteria Migrate Throughout the Body?

How do bacteria and antigens migrate from their normal gut environment to trigger autoimmune responses in joints, the brain, the heart, and other organs? Read More
Insights
Group 2

Innovations in the Treatment of Autoimmune Diseases

Functional Medicine offers an alternative to symptom suppression—by addressing the underlying mechanisms that cause autoimmunity, we can prevent, and in some cases reverse, autoimmune diseases. Read More
Insights
Group 2

Research Continues to Link Genes to Autoimmune Disease

Despite some commonalities, the genetic heritability of autoimmune diseases is exceedingly variable, ranging from very high in Crohn's disease and ankylosing spondylitis to almost negligible in systemic sclerosis. One estimate is that less than 15% of genes related to autoimmune risk have been identified. Read More
Insights
Group 2

The Hygiene Hypothesis & Helminth Treatments With Parasitic Worms

Humans evolved with many parasites. At high doses, hookworm infection causes gastrointestinal symptoms and anemia, but in small doses, hookworms modulate the immune response, increasing immune tolerance. Read More
Insights
Group 2

Understanding Autoimmunity in the Pediatric Population

Pediatric autoimmune conditions are multifarious and affect every aspect of a patient’s life—spiritual, mental, emotional, and physical. As diagnoses continue to rise, only treatments that address the right cause will have lasting benefit beyond symptom suppression for this vulnerable population. Read More
Insights
Group 2

Rise of Autoimmune Disease Linked to Intestinal Permeability

It is well known that the interaction between genes and the environment is fundamental to the immune response. Increasingly, research is validating a new model where genetic susceptibility coupled with increased intestinal permeability sets the stage for a specific environmental trigger. Read More
Insights
Group 2

What Treatment Modalities Improve Quality of Life for Autoimmune Patients?

Up to half of rheumatoid arthritis patients leave the workforce less than 10 years after disease onset. Expanding therapeutic options can make a difference. Read More
Insights
Group 2

Fasano’s Triad and the Trajectory of Autoimmunity

Over the past 20 years, increasing evidence supports Alessio Fasano’s theory that a single protein is critical for triggering autoimmune disorders. Read More